drugset / Trial / NCT04201938

Effect of Probiotic Co-administration With Omega-3 Fatty Acids on Obesity Parameters and Insulin Resistance

NCT04201938 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Omega-3 fatty acids belong to the family of polyunsaturated fatty acids. They are known to exert a strong positive influence on metabolism and inflammation. The data from animal studies suggested that both probiotics and omega-3 can affect body weight, influence on glucose and fat metabolism, improve insulin sensitivity and reduce chronic systemic inflammation. In respect to experimental data, the current study aim was to provide double-blind single center RCT, for study the efficacy of co-administration of probiotic with omega-3 vs. placebo in type 2 diabetes patient

Timeline

Start
2018-02-01
Primary completion
2018-03-01
Completion
2019-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Symbiter-Omega Other / unclassified 10 g —